<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="The Incidence of Pulmonary Embolism and Associated FDG-PET Findings in IV Contrast-Enhanced PET/CT" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/the-incidence-of-pulmonary-embolism-and-associated-fdg-pet-findings-in-iv-contrast-enhanced-pet-ct/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/the-incidence-of-pulmonary-embolism-and-associated-fdg-pet-findings-in-iv-contrast-enhanced-pet-ct/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2014-05-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="The Incidence of Pulmonary Embolism and Associated FDG-PET Findings in IV Contrast-Enhanced PET/CT" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2014-05-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"The Incidence of Pulmonary Embolism and Associated FDG-PET Findings in IV Contrast-Enhanced PET/CT","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/the-incidence-of-pulmonary-embolism-and-associated-fdg-pet-findings-in-iv-contrast-enhanced-pet-ct/"},"url":"https://clinicaltree.github.io/posts/the-incidence-of-pulmonary-embolism-and-associated-fdg-pet-findings-in-iv-contrast-enhanced-pet-ct/"}</script><title>The Incidence of Pulmonary Embolism and Associated FDG-PET Findings in IV Contrast-Enhanced PET/CT | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>The Incidence of Pulmonary Embolism and Associated FDG-PET Findings in IV Contrast-Enhanced PET/CT</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>The Incidence of Pulmonary Embolism and Associated FDG-PET Findings in IV Contrast-Enhanced PET/CT</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1401555600" data-df="ll" data-toggle="tooltip" data-placement="bottom"> May 31, 2014 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Robert R. Flavell MD PhD</a> </em>, <em> <a href="">Spencer C. Behr MD</a> </em>, <em> <a href="">Ryan L. Brunsing MD PhD</a> </em>, <em> <a href="">David M. Naeger MD</a> </em>, <em> <a href="">Miguel Hernez Pampaloni MD PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2082 words"> <em>11 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Most fluorine-18 fluorodeoxyglucose (FDG)-positron emission tomography with computed tomography (PET/CT) studies are performed on cancer patients. These patients are at increased risk of pulmonary embolism (PE). In this retrospective review, we determined the rate of PE, and the prevalence of associated FDG-PET findings on intravenous (IV) contrast-enhanced PET/CT.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>We identified all PET/CT studies performed at our institution with a reported finding of PE between January 2005 and October 2012. The medical record was reviewed for symptoms, which were identified after the diagnosis of PE, and whether the patients received treatment. The prevalence of associated FDG-PET findings was determined.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>A total of 65 total cases of PE (of 182,72 total PET/CT examinations) were identified of which 59 were previously unknown. This gives an incidental PE (IPE) rate of 0.32%. Of the patients where sufficient clinical information was available, 34 of 36 (94%) were treated either with therapeutic anticoagulation or inferior vena cava filter, and 30 of 36 (83%) were asymptomatic in retrospect. Of the patients with IPE, we found nine (15.2%) with associated focal pulmonary artery hypermetabolism, three (5.1%) with hypermetabolic pulmonary infarction, and one with increased isolated right ventricular FDG uptake (1.7%). One case of chronic PE demonstrated a focal hypometabolic filling defect in a pulmonary artery on PET.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>We found IPE in 0.32% of PET/CT scans. Focal pulmonary artery hypermetabolism or hypometabolism, and hypermetabolic pulmonary artery infarction with the “rim sign” were uncommonly associated with PE. These findings could raise the possibility of IPE in non-IV contrast-enhanced PET/CT studies.</p><p>Acute pulmonary embolism (PE) represents a potential life threatening complication of venous thrombosis and is notoriously variable in presentation. Oncology patients have a higher risk of PE and often present without the typical clinical manifestations . These so-called asymptomatic PEs are clinically significant in oncology patients. They serve as a marker for future symptomatic venous thromboembolism (VTE), a term that encompasses both deep venous thrombosis (DVT) and PE , and are associated with decreased survival . The current consensus is for therapeutic intervention in these patients despite the absence of symptoms .</p><p>Several previous studies have investigated the rates of incidental PE (IPE) on contrast-enhanced computed tomography (CT) studies in the oncologic population, with reported rates ranging from 0.58% to 4.0% . Since its approval by the Food and Drug Administration in 2000, fluorine-18 fluorodeoxyglucose (FDG)-positron emission tomography fused with concurrent computed tomography (PET/CT) has rapidly evolved into a cornerstone imaging modality in oncology. At our institution, approximately 95% of PET/CT studies are performed in patients with known or suspected malignancy, and the routine imaging protocol includes intravenous (IV) contrast. In general, most centers perform low-dose, noncontrast-enhanced CT as part of their routine FDG-PET/CT protocol. At our institution, there is a consensus between referring clinicians and the radiology department that patients undergoing PET/CT have a contrast-enhanced diagnostic quality CT unless there is a contraindication such as renal failure or contrast allergy. One previous study found IPE in 13 of 2216 patients (0.59%) who had a contrast-enhanced PET/CT . The aim of our study was to evaluate the incidence of IPE in patients referred for FDG-PET/CT studies in a much larger cohort. An additional goal was to identify and characterize associated PET findings and their relative frequency.</p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="patient-selection"><span class="mr-2">Patient Selection</span><a href="#patient-selection" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="scan-technique"><span class="mr-2">Scan Technique</span><a href="#scan-technique" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging-and-chart-review"><span class="mr-2">Imaging and Chart Review</span><a href="#imaging-and-chart-review" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="total-number-of-cases-reviewed"><span class="mr-2">Total Number of Cases Reviewed</span><a href="#total-number-of-cases-reviewed" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="incidence-of-pe"><span class="mr-2">Incidence of PE</span><a href="#incidence-of-pe" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Pulmonary Embolism Characteristics</p><p>Total IV contrast-enhanced PET/CT scans ∗ 18,272 Number of cases with PE 65 Number of cases of incidental PE 59 (0.32%) Number of cases with chronic PE 6 Location in pulmonary artery Main PA 9/59 (15%) Lobar PA 15/59 (25%) Segmental PA 27/59 (46%) Subsegmental PA 8/59 (14%)</p><p>IV, intravenous; PA, pulmonary artery; PE, pulmonary embolism; PET/CT, positron emission tomography with computed tomography.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Demographics of Patients with IPE</p><p>Age Mean 55.8 Standard deviation 15 Range 23–84 Malignant neoplasm ∗ 57/59 (97%) Metastases 34/51 (67%) Female 30/59 (51%) Male 29/59 (49%) Treatment † Chemotherapy 30/47 (64%) Surgery 13/47 (28%) Radiation 7/47 (15%) None 19/47 (21%)</p><p>IPE, incidental pulmonary embolism.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Characteristics of Tumors</p><p>Type # IPE Total ∗ Incidence ∗ Breast 13 2563 0.51% Melanoma 10 2839 0.35% Lymphoma 6 Lung 5 Esophageal 4 Colon 3 Anorectal 2 Ewing’s sarcoma 2 Multiple myeloma 2 Other 10 No malignancy 2</p><p>IPE, incidental pulmonary embolism.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="pulmonary-emboli-characteristics"><span class="mr-2">Pulmonary Emboli Characteristics</span><a href="#pulmonary-emboli-characteristics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="clinical-symptoms-and-treatment-with-anticoagulation"><span class="mr-2">Clinical Symptoms and Treatment with Anticoagulation</span><a href="#clinical-symptoms-and-treatment-with-anticoagulation" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="review-of-associated-fdg-pet-findings"><span class="mr-2">Review of Associated FDG-PET Findings</span><a href="#review-of-associated-fdg-pet-findings" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 4</p><p>PET Findings Associated with IPE</p><p>High SUV in right ventricle 1/59 (2%) Hypermetabolic pulmonary infarction 3/59 (5%) Hypermetabolic pulmonary artery 9/59 (15%) Mean SUV 2.2 ± 0.7 Max SUV 3.2 Main PA 1/9 Lobar PA 2/9 Segmental PA 4/9 Subsegmental PA 2/9</p><p>IPE, incidental pulmonary embolism; PA, pulmonary artery; SUV, standardized uptake value.</p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheIncidenceofPulmonaryEmbolismandAssociatedFDGPETFindingsinIVContrastEnhancedPETCT/0_1s20S1076633214000920.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheIncidenceofPulmonaryEmbolismandAssociatedFDGPETFindingsinIVContrastEnhancedPETCT/0_1s20S1076633214000920.jpg" alt="Figure 1, Example of pulmonary artery hypermetabolism. A 75-year-old woman with history of melanoma. (a) Incidental right lower lobe segmental pulmonary embolism seen on computed tomography. (b) The associated PET demonstrates mild focal pulmonary arterial hypermetabolism, with an SUV max of 2.0. PET, positron emission tomography; SUV, standardized uptake value." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheIncidenceofPulmonaryEmbolismandAssociatedFDGPETFindingsinIVContrastEnhancedPETCT/1_1s20S1076633214000920.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheIncidenceofPulmonaryEmbolismandAssociatedFDGPETFindingsinIVContrastEnhancedPETCT/1_1s20S1076633214000920.jpg" alt="Figure 2, Example showing hypometabolism in chronic pulmonary embolism. A 66-year-old man with history of non-Hodgkin's lymphoma. (a) Contrast-enhanced CT demonstrates a calcified, eccentrically located filling defect in the right main pulmonary artery. This defect had been present on previous CTs and is consistent with a chronic pulmonary embolism. (b) The associated PET demonstrates a hypometabolic pulmonary arterial filling defect. CT, computed tomography; PET, positron emission tomography." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheIncidenceofPulmonaryEmbolismandAssociatedFDGPETFindingsinIVContrastEnhancedPETCT/2_1s20S1076633214000920.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheIncidenceofPulmonaryEmbolismandAssociatedFDGPETFindingsinIVContrastEnhancedPETCT/2_1s20S1076633214000920.jpg" alt="Figure 3, - Example of peripheral pulmonary infarction with associated complete rim of FDG avidity. A 66-year-old woman with a history of gastric cancer. Contrast-enhanced computed tomography demonstrates a pulmonary embolism involving the interlobar pulmonary artery (a) and a right lower lobe pulmonary infarction (b) . The associated PET demonstrates a rim of FDG avidity at the borders of the infarction (c) . FDG, fluorodeoxyglucose; PET, positron emission tomography." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheIncidenceofPulmonaryEmbolismandAssociatedFDGPETFindingsinIVContrastEnhancedPETCT/3_1s20S1076633214000920.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheIncidenceofPulmonaryEmbolismandAssociatedFDGPETFindingsinIVContrastEnhancedPETCT/3_1s20S1076633214000920.jpg" alt="Figure 4, Example of peripheral pulmonary infarction with associated FDG avidity. A 61-year-old woman with history of breast cancer. Contrast-enhanced computed tomography demonstrates a segmental left lower lobe pulmonary embolism (a) and a small left lower lobe pulmonary infarction (b) . The associated PET demonstrates an incomplete rim of FDG avidity surrounding the area of the infarction (c) . FDG, fluorodeoxyglucose; PET, positron emission tomography." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheIncidenceofPulmonaryEmbolismandAssociatedFDGPETFindingsinIVContrastEnhancedPETCT/4_1s20S1076633214000920.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheIncidenceofPulmonaryEmbolismandAssociatedFDGPETFindingsinIVContrastEnhancedPETCT/4_1s20S1076633214000920.jpg" alt="Figure 5, Example showing increased right ventricular uptake. A 29-year-old woman with metastatic melanoma. (a) Saddle pulmonary embolus was seen on contrast-enhanced CT. (b) CT demonstrating bowing of the interventricular septum. (c) PET demonstrating near-circumferential increased FDG uptake in the right ventricular wall. CT, computed tomography; FDG, fluorodeoxyglucose; PET, positron emission tomography." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusions-1"><span class="mr-2">Conclusions</span><a href="#conclusions-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="supplementary-data"><span class="mr-2">Supplementary Data</span><a href="#supplementary-data" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Supplemental Figures1–4</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. den Exter P.L., Jimenez D., Kroft L.J., et. al.: Outcome of incidentally diagnosed pulmonary embolism in patients with malignancy. Curr Opin Pulm Med 2012; 18: pp. 399-405.</p><li><p>2. Heit J.A., Silverstein M.D., Mohr D.N., et. al.: Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160: pp. 809-815.</p><li><p>3. Fulkerson W.J., Coleman R.E., Ravin C.E., et. al.: Diagnosis of pulmonary embolism. Arch Intern Med 1986; 146: pp. 961-967.</p><li><p>4. den Exter P.L., Hooijer J., Dekkers O.M., et. al.: Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol 2011; 29: pp. 2405-2409.</p><li><p>5. Sorensen H.T., Mellemkjaer L., Olsen J.H., et. al.: Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000; 343: pp. 1846-1850.</p><li><p>6. Gladish G.W., Choe D.H., Marom E.M., et. al.: Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history. Radiology 2006; 240: pp. 246-255.</p><li><p>7. Sebastian A.J., Paddon A.J.: Clinically unsuspected pulmonary embolism—an important secondary finding in oncology CT. Clin Radiol 2006; 61: pp. 81-85.</p><li><p>8. Cronin C.G., Lohan D.G., Keane M., et. al.: Prevalence and significance of asymptomatic venous thromboembolic disease found on oncologic staging CT. AJR Am J Roentgenol 2007; 189: pp. 162-170.</p><li><p>9. Rita Larici A., Calandriello L., Maggi F., et. al.: Prevalence of incidental pulmonary emboli in oncology patients. Radiology 2007; 245: pp. 921-922. author reply—2</p><li><p>10. Browne A.M., Cronin C.G., English C., et. al.: Unsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imaging. J Thorac Oncol 2010; 5: pp. 798-803.</p><li><p>11. Gladish G.W., Erasmus J.J.: Unsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imaging. J Thorac Oncol 2010; 5: pp. 759-760.</p><li><p>12. Abdel-Razeq H.N., Mansour A.H., Ismael Y.M.: Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome—a comprehensive cancer center experience. Vasc Health Risk Manag 2011; 7: pp. 153-158.</p><li><p>13. Wittram C., Scott J.A.: 18F-FDG PET of pulmonary embolism. AJR Am J Roentgenol 2007; 189: pp. 171-176.</p><li><p>14. Wittram C., Maher M.M., Yoo A.J., et. al.: CT angiography of pulmonary embolism: diagnostic criteria and causes of misdiagnosis. Radiographics 2004; 24: pp. 1219-1238.</p><li><p>15. Di Nisio M., Ferrante N., De Tursi M., et. al.: Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Thromb Haemost 2010; 104: pp. 1049-1054.</p><li><p>16. Menapace L.A., Peterson D.R., Berry A., et. al.: Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer. Thromb Haemost 2010; 106: pp. 371-378.</p><li><p>17. Revel M.P., Triki R., Chatellier G., et. al.: Is it possible to recognize pulmonary infarction on multisection CT images?. Radiology 2007; 244: pp. 875-882.</p><li><p>18. Blom J.W., Doggen C.J., Osanto S., et. al.: Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293: pp. 715-722.</p><li><p>19. Caine G.J., Stonelake P.S., Lip G.Y., et. al.: The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia (New York, NY) 2002; 4: pp. 465-473.</p><li><p>20. Khorana A.A., Francis C.W., Culakova E., et. al.: Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 2007; 5: pp. 632-634.</p><li><p>21. Dentali F., Ageno W., Becattini C., et. al.: Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis. Thromb Res 2010; 125: pp. 518-522.</p><li><p>22. Goethals I., Smeets P., De Winter O., et. al.: Focally enhanced f-18 fluorodeoxyglucose (FDG) uptake in incidentally detected pulmonary embolism on PET/CT scanning. Clin Nucl Med 2006; 31: pp. 497-498.</p><li><p>23. Ito K., Kubota K., Morooka M., et. al.: Diagnostic usefulness of 18F-FDG PET/CT in the differentiation of pulmonary artery sarcoma and pulmonary embolism. Ann Nucl Med 2009; 23: pp. 671-676.</p><li><p>24. Lee E.J., Moon S.H., Choi J.Y., et. al.: Usefulness of fluorodeoxyglucose positron emission tomography in malignancy of pulmonary artery mimicking pulmonary embolism. ANZ J Surg 2013; 83: pp. 342-347.</p><li><p>25. Franceschi A.M., Matthews R., Mankes S., et. al.: Four chamber FDG uptake in the heart: an indirect sign of pulmonary embolism. Clin Nucl Med 2012; 37: pp. 687-691.</p><li><p>26. Badr A., Joyce J.M., Durick J.: Rim of FDG uptake around a pulmonary infarct on PET/CT in a patient with unsuspected pulmonary embolism. Clin Nucl Med 2009; 34: pp. 285-286.</p><li><p>27. Soussan M., Rust E., Pop G., et. al.: The rim sign: FDG-PET/CT pattern of pulmonary infarction. Insights Imaging 2012; 3: pp. 629-633.</p><li><p>28. Farsad M., Ambrosini V., Nanni C., et. al.: Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings. Nucl Med Commun 2005; 26: pp. 827-830.</p><li><p>29. Bernard J., Yi E.S.: Pulmonary thromboendarterectomy: a clinicopathologic study of 200 consecutive pulmonary thromboendarterectomy cases in one institution. Hum Pathol 2007; 38: pp. 871-877.</p><li><p>30. Kamel E.M., McKee T.A., Calcagni M.L., et. al.: Occult lung infarction may induce false interpretation of 18F-FDG PET in primary staging of pulmonary malignancies. Eur J Nucl Med Mol Imaging 2005; 32: pp. 641-646.</p><li><p>31. Reid J.H., Murchison J.T.: Acute right ventricular dilatation: a new helical CT sign of massive pulmonary embolism. Clin Radiol 1998; 53: pp. 694-698.</p><li><p>32. Oikawa M., Kagaya Y., Otani H., et. al.: Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol 2005; 45: pp. 1849-1855.</p><li><p>33. Basu S., Alzeair S., Li G., et. al.: Etiopathologies associated with intercostal muscle hypermetabolism and prominent right ventricle visualization on 2-deoxy-2[F-18]fluoro- d -glucose-positron emission tomography: significance of an incidental finding and in the setting of a known pulmonary disease. Mol Imaging Biol 2007; 9: pp. 333-339.</p><li><p>34. Bokhari S., Raina A., Rosenweig E.B., et. al.: PET imaging may provide a novel biomarker and understanding of right ventricular dysfunction in patients with idiopathic pulmonary arterial hypertension. Circulation 2011; 4: pp. 641-647.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-21/'>Volume 21</a>, <a href='/categories/issue-6/'>Issue 6</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=The%20Incidence%20of%20Pulmonary%20Embolism%20and%20Associated%20FDG-PET%20Findings%20in%20IV%20Contrast-Enhanced%20PET/CT%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fthe-incidence-of-pulmonary-embolism-and-associated-fdg-pet-findings-in-iv-contrast-enhanced-pet-ct%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=The%20Incidence%20of%20Pulmonary%20Embolism%20and%20Associated%20FDG-PET%20Findings%20in%20IV%20Contrast-Enhanced%20PET/CT%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fthe-incidence-of-pulmonary-embolism-and-associated-fdg-pet-findings-in-iv-contrast-enhanced-pet-ct%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fthe-incidence-of-pulmonary-embolism-and-associated-fdg-pet-findings-in-iv-contrast-enhanced-pet-ct%2F&text=The%20Incidence%20of%20Pulmonary%20Embolism%20and%20Associated%20FDG-PET%20Findings%20in%20IV%20Contrast-Enhanced%20PET/CT%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/assessment-of-tumor-grade-and-angiogenesis-in-colorectal-cancer/"><div class="card-body"> <em class="small" data-ts="1401555600" data-df="ll" > May 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Assessment of Tumor Grade and Angiogenesis in Colorectal Cancer</h3><div class="text-muted small"><p> Rationale and Objectives The preoperative evaluation of tumor grading and angiogenesis has important clinical implications in the treatment and prognosis of patients with colorectal cancers (CRCs)...</p></div></div></a></div><div class="card"> <a href="/posts/contrast-enhanced-magnetic-resonance-angiog-raphy-for-the-preoperative-evaluation-of-hepatic-vascula/"><div class="card-body"> <em class="small" data-ts="1401555600" data-df="ll" > May 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Contrast-enhanced Magnetic Resonance Angiog raphy for the Preoperative Evaluation of Hepatic Vascular Anatomy in Living Liver Donors</h3><div class="text-muted small"><p> Rationale and Objectives The objective of this study was to determine the diagnostic accuracy of contrast-enhanced magnetic resonance angiography (MRA) when used in the preoperative evaluation of ...</p></div></div></a></div><div class="card"> <a href="/posts/evaluation-of-coronary-artery-image-quality-with-knowledge-based-iterative-model-reconstruction/"><div class="card-body"> <em class="small" data-ts="1401555600" data-df="ll" > May 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Evaluation of Coronary Artery Image Quality with Knowledge-based Iterative Model Reconstruction</h3><div class="text-muted small"><p> Rationale and Objectives To evaluate knowledge-based iterative model reconstruction (IMR) to improve image quality and reduce radiation dose in coronary computed tomography angiography (cCTA). Ma...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/the-diagnostic-and-grading-value-of-diffusion-tensor-imaging-in-patients-with-carpal-tunnel-syndrome/" class="btn btn-outline-primary" prompt="Older"><p>The Diagnostic and Grading Value of Diffusion Tensor Imaging in Patients with Carpal Tunnel Syndrome</p></a> <a href="/posts/thymic-measurements-in-pathologically-proven-normal-thymus-and-thymic-hyperplasia/" class="btn btn-outline-primary" prompt="Newer"><p>Thymic Measurements in Pathologically Proven Normal Thymus and Thymic Hyperplasia</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
